Identification of Four Novel Associations for B-cell Acute Lymphoblastic Leukaemia Risk

Jayaram Vijayakrishnan,Maoxiang Qian,James B. Studd,Wenjian Yang,Ben Kinnersley,Philip J. Law,Peter Broderick,Elizabeth A. Raetz,James Allan,Ching-Hon Pui,Ajay Vora,William E. Evans,Anthony Moorman,Allen Yeoh,Wentao Yang,Chunliang Li,Claus R. Bartram,Charles G. Mullighan,Martin Zimmerman,Stephen P. Hunger,Martin Schrappe,Mary V. Relling,Martin Stanulla,Mignon L. Loh,Richard S. Houlston,Jun J. Yang
DOI: https://doi.org/10.1038/s41467-019-13069-6
IF: 16.6
2019-01-01
Nature Communications
Abstract:There is increasing evidence for a strong inherited genetic basis of susceptibility to acute lymphoblastic leukaemia (ALL) in children. To identify new risk variants for B-cell ALL (B-ALL) we conducted a meta-analysis with four GWAS (genome-wide association studies), totalling 5321 cases and 16,666 controls of European descent. We herein describe novel risk loci for B-ALL at 9q21.31 (rs76925697, P = 2.11 × 10 −8 ), for high-hyperdiploid ALL at 5q31.1 (rs886285, P = 1.56 × 10 −8 ) and 6p21.31 (rs210143 in BAK1 , P = 2.21 × 10 −8 ), and ETV6-RUNX1 ALL at 17q21.32 (rs10853104 in IGF2BP1 , P = 1.82 × 10 −8 ). Particularly notable are the pleiotropic effects of the BAK1 variant on multiple haematological malignancies and specific effects of IGF2BP1 on ETV6-RUNX1 ALL evidenced by both germline and somatic genomic analyses. Integration of GWAS signals with transcriptomic/epigenomic profiling and 3D chromatin interaction data for these leukaemia risk loci suggests deregulation of B-cell development and the cell cycle as central mechanisms governing genetic susceptibility to ALL.
What problem does this paper attempt to address?